Bob Yedid | LifeSci Advisors |
Avanish Vellanki | Chief Executive Officer |
Nelson Cabatuan | Senior Vice President of Finance |
Bob Deobele | President and Chief Scientific Officer |
Richard Bryce | Chief Medical Officer |
Yige Guo | Guggenheim |
Sam Kurtz | Piper Sandler |
Jeff Jones | Oppenheimer |
Soumit Roy | Jones Research |
Tony Butler | ROTH Capital |
Good day, and welcome to the Rain Therapeutics Second Quarter 2022 Earnings Conference Call. Today’s conference is being recorded. At this time, I’d like to turn the conference over to Bob Yedid. Please go ahead.
Thank you, operator, and good afternoon, everyone.